{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:28:20Z","timestamp":1786588100014,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,13]]},"group-title":"In Review","reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,16]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background<\/bold>\n                  Pathological high-frequency oscillations (HFOs), widely researched in epilepsy, are increasingly being investigated as potential biomarkers of network hyperexcitability in neurodegenerative disorders. This interest is driven by growing evidence of comorbidity between epilepsy and neurodegenerative diseases, particularly Alzheimer\u2019s disease (AD) and dementia with Lewy bodies (DLB), suggesting that these HFOs could be useful biomarkers in these disorders. Patients with AD and mouse models of AD exhibit elevated HFOs during neurophysiology recordings, but whether HFOs occur in DLB remains unknown.\n                  <bold>Methods<\/bold>\n                  To address this question, we quantified cortical HFOs within the spectral range of 250\u2013500 Hz and interictal spikes using surface electroencephalography recordings in a transgenic model of \u03b1-synucleinopathy that exhibits features of DLB (A53T mice) and a model of channelopathy-induced epilepsy (\n                  <italic>Kcna1<\/italic>\n                  -\/- mice) .\n                  <bold>Results<\/bold>\n                  Both A53T and\n                  <italic>Kcna1<\/italic>\n                  -\/- mice exhibited significantly more HFOs than their respective control mice across all vigilance states. A53T mice exhibited more HFOs and interictal spikes than\n                  <italic>Kcna1<\/italic>\n                  -\/- mice, and the HFOs in A53T mice had higher frequencies and longer durations than those in\n                  <italic>Kcna1<\/italic>\n                  -\/- mice. Additionally, HFOs were most prevalent during non-REM sleep in A53T mice, coinciding with the vigilance state in which interictal spikes were most frequent in this model. However, they did not consistently co-occur with interictal spikes or seizures, and HFO counts did not correlate with interictal spike counts during 10-minute recording epochs.\n                  <bold>Conclusions<\/bold>\n                  Our findings indicate that HFOs likely arise from different neuronal populations and are generated through distinct mechanisms in these two models. Importantly, this work shows that HFOs are an electroencephalographic abnormality in a model of DLB and supports their potential as a new biomarker for neurodegenerative disorders.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10385398\/v1","type":"posted-content","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:02:34Z","timestamp":1786586554000},"source":"Crossref","is-referenced-by-count":0,"title":["High-frequency oscillations arise through distinct mechanisms in models of \u03b1- synucleinopathy and channelopathy-induced epilepsy"],"prefix":"10.21203","author":[{"given":"Rahil N.","family":"Vaknalli","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku","family":"Addo-Osafo","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu Shandilya M","family":"C","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylin","family":"Hwang","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane","family":"Vicente","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Bragin","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Vossel","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1021\/acschemneuro.8b00281","article-title":"Identification of GSK-3 as a potential therapeutic entry point for epilepsy","volume":"10","author":"Aourz N","year":"2019","unstructured":"Aourz, N. et al. Identification of GSK-3 as a potential therapeutic entry point for epilepsy. ACS Chem. Neurosci. 10, 1992\u20132003. 10.1021\/acschemneuro.8b00281 (2019).","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"ref2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia","volume":"60","author":"Beagle AJ","year":"2017","unstructured":"Beagle, A. J. et al. Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia. J. Alzheimers Dis. 60 (1), 211\u2013223. 10.3233\/JAD-170031 (2017).","journal-title":"J. Alzheimers Dis."},{"issue":"15","key":"ref3","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1523\/JNEUROSCI.5591-09.2010","article-title":"Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy","volume":"30","author":"Glasscock E","year":"2010","unstructured":"Glasscock, E., Yoo, J. W., Chen, T. T., Klassen, T. L. & Noebels, J. L. Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy. J. neuroscience: official J. Soc. Neurosci. 30 (15), 5167\u20135175. https:\/\/doi.org\/10.1523\/JNEUROSCI.5591-09.2010 (2010).","journal-title":"J. neuroscience: official J. Soc. Neurosci."},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy","volume":"33","author":"Holth JK","year":"2013","unstructured":"Holth, J. K. et al. Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J. neuroscience: official J. Soc. Neurosci. 33 (4), 1651\u20131659. https:\/\/doi.org\/10.1523\/JNEUROSCI.3191-12.2013 (2013).","journal-title":"J. neuroscience: official J. Soc. Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"903973","DOI":"10.3389\/fnagi.2022.903973","article-title":"Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms","volume":"14","author":"Hwang K","year":"2022","unstructured":"Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M. & Vossel, K. Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms. Front. Aging Neurosci. 14, 903973. https:\/\/doi.org\/10.3389\/fnagi.2022.903973 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/mds.28566","article-title":"High-Frequency Oscillations in the Pallidum: A Pathophysiological Biomarker in Parkinson's Disease?","volume":"36","author":"Johnson LA","year":"2021","unstructured":"Johnson, L. A. et al. High-Frequency Oscillations in the Pallidum: A Pathophysiological Biomarker in Parkinson's Disease? Mov. disorders: official J. Mov. Disorder Soc. 36 (6), 1332\u20131341. https:\/\/doi.org\/10.1002\/mds.28566 (2021).","journal-title":"Mov. disorders: official J. Mov. Disorder Soc."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2014.11.008","article-title":"The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy","volume":"25","author":"L\u00e9vesque M","year":"2015","unstructured":"L\u00e9vesque, M., Behr, C. & Avoli, M. The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy. Seizure 25, 18\u201325. https:\/\/doi.org\/10.1016\/j.seizure.2014.11.008 (2015).","journal-title":"Seizure"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"105637","DOI":"10.1016\/j.nbd.2022.105637","article-title":"Robust chronic convulsive seizures, high frequency oscillations, and human seizure onset patterns in an intrahippocampal kainic acid model in mice","volume":"166","author":"Lisgaras CP","year":"2022","unstructured":"Lisgaras, C. P. & Scharfman, H. E. Robust chronic convulsive seizures, high frequency oscillations, and human seizure onset patterns in an intrahippocampal kainic acid model in mice. Neurobiol. Dis. 166, 105637. 10.1016\/j.nbd.2022.105637 (2022).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/epi.17462","article-title":"High-frequency oscillations (250\u2013500 Hz) in animal models of Alzheimer's disease and two animal models of epilepsy","volume":"64","author":"Lisgaras CP","year":"2023","unstructured":"Lisgaras, C. P. & Scharfman, H. E. High-frequency oscillations (250\u2013500 Hz) in animal models of Alzheimer's disease and two animal models of epilepsy. Epilepsia 64 (1), 231\u2013246. 10.1111\/epi.17462 (2023).","journal-title":"Epilepsia"},{"issue":"7","key":"ref10","doi-asserted-by":"publisher","first-page":"e70386","DOI":"10.1002\/alz.70386","article-title":"High-frequency oscillations\u2009>\u2009250 Hz in people with Down syndrome and associated Alzheimer's disease dementia","volume":"21","author":"Lisgaras CP","year":"2025","unstructured":"Lisgaras, C. P. et al. High-frequency oscillations\u2009>\u2009250 Hz in people with Down syndrome and associated Alzheimer's disease dementia. Alzheimer's Dement. J. Alzheimer's Assoc. 21 (7), e70386. https:\/\/doi.org\/10.1002\/alz.70386 (2025).","journal-title":"Alzheimer's Dement. J. Alzheimer's Assoc."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.pneurobio.2025.102844","article-title":"Opposing interictal dynamics in Alzheimer's disease and epilepsy","volume":"256","author":"Lisgaras CP","year":"2026","unstructured":"Lisgaras, C. P. & Scharfman, H. E. Opposing interictal dynamics in Alzheimer's disease and epilepsy. Prog. Neurobiol. 256, 102844. https:\/\/doi.org\/10.1016\/j.pneurobio.2025.102844 (2026).","journal-title":"Prog. Neurobiol."},{"issue":"Pt 7","key":"ref12","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/brain\/aww116","article-title":"Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau","volume":"139","author":"Liu SJ","year":"2016","unstructured":"Liu, S. J. et al. Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau. Brain: J. Neurol. 139 (Pt 7), 1919\u20131938. https:\/\/doi.org\/10.1093\/brain\/aww116 (2016).","journal-title":"Brain: J. Neurol."},{"issue":"8","key":"ref13","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1152\/jn.00341.2013","article-title":"Pathological and physiological high-frequency oscillations in focal human epilepsy","volume":"110","author":"Matsumoto A","year":"2013","unstructured":"Matsumoto, A. et al. Pathological and physiological high-frequency oscillations in focal human epilepsy. J. Neurophysiol. 110 (8), 1958\u20131964. https:\/\/doi.org\/10.1152\/jn.00341.2013 (2013).","journal-title":"J. Neurophysiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"785328","DOI":"10.3389\/fnbeh.2021.785328","article-title":"Characterizing Hippocampal Oscillatory Signatures Underlying Seizures in Temporal Lobe Epilepsy","volume":"15","author":"Mokhothu TM","year":"2021","unstructured":"Mokhothu, T. M. & Tanaka, K. Z. Characterizing Hippocampal Oscillatory Signatures Underlying Seizures in Temporal Lobe Epilepsy. Front. Behav. Neurosci. 15, 785328. https:\/\/doi.org\/10.3389\/fnbeh.2021.785328 (2021).","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"e0158276","DOI":"10.1371\/journal.pone.0158276","article-title":"RIPPLELAB: A Comprehensive Application for the Detection, Analysis and Classification of High Frequency Oscillations in Electroencephalographic Signals","volume":"11","author":"Navarrete M","year":"2016","unstructured":"Navarrete, M., Alvarado-Rojas, C., Le Van Quyen, M. & Valderrama, M. RIPPLELAB: A Comprehensive Application for the Detection, Analysis and Classification of High Frequency Oscillations in Electroencephalographic Signals. PLoS One. 11 (6), e0158276. 10.1371\/journal.pone.0158276 (2016).","journal-title":"PLoS One"},{"issue":"4","key":"ref16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop JJ","year":"2009","unstructured":"Palop, J. J. & Mucke, L. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66 (4), 435\u2013440. https:\/\/doi.org\/10.1001\/archneurol.2009.15 (2009).","journal-title":"Arch. Neurol."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fneur.2020.00563","article-title":"Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human alpha-Synuclein","volume":"11","author":"Peters ST","year":"2020","unstructured":"Peters, S. T. et al. Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human alpha-Synuclein. Front. Neurol. 11, 563 (2020).","journal-title":"Front. Neurol."},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"fcaf041","DOI":"10.1093\/braincomms\/fcaf041","article-title":"High-frequency oscillations in epileptic and non-epileptic Alzheimer's disease patients and the differential effect of levetiracetam on the oscillations","volume":"7","author":"Shandilya MCV","year":"2025","unstructured":"Shandilya, M. C. V. et al. High-frequency oscillations in epileptic and non-epileptic Alzheimer's disease patients and the differential effect of levetiracetam on the oscillations. Brain Commun. 7 (1), fcaf041. https:\/\/doi.org\/10.1093\/braincomms\/fcaf041 (2025).","journal-title":"Brain Commun."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.nbd.2013.02.009 10.3389\/fneur.2020.00563","article-title":"Loss of the Kv1.1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices","volume":"54","author":"Simeone TA","year":"2013","unstructured":"Simeone, T. A., Simeone, K. A., Samson, K. K., Kim, D. Y. & Rho, J. M. Loss of the Kv1.1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices. Neurobiol. Dis. 54, 68\u201381. https:\/\/doi.org\/10.1016\/j.nbd.2013.02.009 10.3389\/fneur.2020.00563 (2013).","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"ref20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/s0896-6273(00)81018-1","article-title":"Deletion of the K(V)1.1 potassium channel causes epilepsy in mice","volume":"20","author":"Smart SL","year":"1998","unstructured":"Smart, S. L. et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20 (4), 809\u2013819. https:\/\/doi.org\/10.1016\/s0896-6273(00)81018-1 (1998).","journal-title":"Neuron"},{"issue":"4","key":"ref21","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1152\/jn.2002.88.4.1743","article-title":"Quantitative analysis of high-frequency oscillations (80\u2013500 Hz) recorded in human epileptic hippocampus and entorhinal cortex","volume":"88","author":"Staba RJ","year":"2002","unstructured":"Staba, R. J., Wilson, C. L., Bragin, A., Fried, I. & Engel, J. Jr. Quantitative analysis of high-frequency oscillations (80\u2013500 Hz) recorded in human epileptic hippocampus and entorhinal cortex. J. Neurophysiol. 88 (4), 1743\u20131752. 10.1152\/jn.2002.88.4.1743 (2002).","journal-title":"J. Neurophysiol."},{"issue":"45","key":"ref22","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1523\/JNEUROSCI.0344-18.2018","article-title":"A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes","volume":"38","author":"Teravskis PJ","year":"2018","unstructured":"Teravskis, P. J. et al. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes. J. neuroscience: official J. Soc. Neurosci. 38 (45), 9754\u20139767. https:\/\/doi.org\/10.1523\/JNEUROSCI.0344-18.2018 (2018).","journal-title":"J. neuroscience: official J. Soc. Neurosci."},{"issue":"5","key":"ref23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/cells13050434","article-title":"Firing Alterations of Neurons in Alzheimer's Disease: Are They Merely a Consequence of Pathogenesis or a Pivotal Component of Disease Progression?","volume":"13","author":"Tzavellas NP","year":"2024","unstructured":"Tzavellas, N. P. et al. Firing Alterations of Neurons in Alzheimer's Disease: Are They Merely a Consequence of Pathogenesis or a Pivotal Component of Disease Progression? Cells 13 (5), 434. https:\/\/doi.org\/10.3390\/cells13050434 (2024).","journal-title":"Cells"},{"issue":"14","key":"ref24","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/ijms21145030","article-title":"Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core","volume":"21","author":"Vacchi E","year":"2020","unstructured":"Vacchi, E., Kaelin-Lang, A. & Melli, G. Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core. Int. J. Mol. Sci. 21 (14), 5030. https:\/\/doi.org\/10.3390\/ijms21145030 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"ref25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12264-023-01150-6","article-title":"Pathological and Physiological High-frequency Oscillations on Electroencephalography in Patients with Epilepsy","volume":"40","author":"Ye H","year":"2024","unstructured":"Ye, H., Chen, C., Weiss, S. A. & Wang, S. Pathological and Physiological High-frequency Oscillations on Electroencephalography in Patients with Epilepsy. Neurosci. Bull. 40 (5), 609\u2013620. https:\/\/doi.org\/10.1007\/s12264-023-01150-6 (2024).","journal-title":"Neurosci. Bull."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10385398\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10385398\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:02:36Z","timestamp":1786586556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10385398\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":25,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10385398\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,13]]},"subtype":"preprint"}}